Monday, January 25

Coronavirus vaccines: concern about the hasty approval of Covaxin, the vaccine developed in India

  • Drafting
  • BBC World News


India approved the emergency use of Cobain before completing clinical trials of the vaccine.

Experts have raised concerns about the approval in India of a locally produced coronavirus vaccine before the end of clinical trials.

Indian authorities approved the emergency use of the vaccine Cobain on Sunday, when they also gave the green light to the AstraZeneca and Oxford vaccine, which is being manufactured in the Asian country.

Prime Minister Narendra Modi referred to Cobain’s approval as a turning point in the battle against the pandemic, but health experts called the decision hasty.

The All India Drug Action Network, which tracks health issues, said it was concerned about the news.

style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">

Leave a Reply

Your email address will not be published. Required fields are marked *